Russell Investments Group, Ltd. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 223 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,091
-12.9%
20,8000.0%0.00%
Q2 2023$9,287
-45.5%
20,8000.0%0.00%
Q1 2023$17,056
-47.4%
20,8000.0%0.00%
Q4 2022$32,448
-7.3%
20,8000.0%0.00%
Q3 2022$35,0000.0%20,8000.0%0.00%
Q2 2022$35,000
-52.7%
20,8000.0%0.00%
Q1 2022$74,000
-28.2%
20,8000.0%0.00%
Q4 2021$103,000
-30.4%
20,8000.0%0.00%
Q3 2021$148,000
-47.5%
20,800
-31.7%
0.00%
Q2 2021$282,0000.0%30,4610.0%0.00%
Q1 2021$282,000
+44.6%
30,461
+37.9%
0.00%
Q4 2020$195,000
-46.9%
22,091
-30.4%
0.00%
-100.0%
Q3 2020$367,000
+41.2%
31,752
+228.7%
0.00%0.0%
Q2 2020$260,000
+233.3%
9,661
-48.7%
0.00%
Q4 2017$78,000
-34.5%
18,8350.0%0.00%
Q3 2017$119,000
-74.7%
18,835
-68.6%
0.00%
-100.0%
Q2 2017$471,000
-8.4%
60,027
-22.8%
0.00%0.0%
Q1 2017$514,000
-8.1%
77,709
-3.7%
0.00%0.0%
Q4 2016$559,00080,6910.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Triatomic Management LP 235,000$405,0000.23%
Green Alpha Advisors, LLC 147,380$254,0000.22%
Financial Advocates Investment Management 14,161$628,0000.05%
Virtus ETF Advisers LLC 72,540$125,0000.05%
Cedar Brook Financial Partners, LLC 88,750$153,0940.05%
Rafferty Asset Management, LLC 2,363,189$4,077,0000.04%
Hennion & Walsh Asset Management, Inc. 352,721$608,0000.04%
CAXTON ASSOCIATES LP 130,728$226,0000.03%
Keystone Financial Group 74,058$128,0000.03%
Virtu Financial LLC 130,829$226,0000.02%
View complete list of INOVIO PHARMACEUTICALS INC shareholders